SVETLANA MAMIKONYAN: Open Payments
NPI 1730510918 · BENSALEM, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$305 in 15 payments from 7 companies in 2025. Trend: 2023 $384 · 2024 $490 · 2025 $305
Food & beverage: $305
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $92 |
| Novo Nordisk Inc | 4 | $90 |
| PFIZER INC. | 2 | $35 |
| GlaxoSmithKline, LLC. | 1 | $26 |
| Lilly USA, LLC | 1 | $22 |
| Bausch Health US, LLC | 1 | $22 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
Products named: VRAYLAR, SHINGRIX, Wegovy, MOUNJARO, APLENZIN, NURTEC ODT, REXULTI, ELIQUIS.
Industry payments across PA — which companies pay providers there.
